Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BRIEF: Rituximab and Bendamustine in Elderly Follicular Lymphoma
NCT01313611Phase 2Terminated
- Sponsor
- LYSARC
- Start
- Feb 2011
- Primary completion
- Oct 2012
- Modality
- Small Molecules, Monoclonal Antibodies
- Countries
- 2
01
Overview
A Phase 2 trial of rituximab, bendamustine in follicular lymphoma (FL), sponsored by LYSARC. Started Feb 2011; status: terminated.
02
Drugs
rituximabbendamustine
03
Conditions
follicular lymphoma (FL)
Beyond the preview
Go deeper on NCT01313611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01313611.